CXCR5 and chronic myelogenous leukemia, BCR-ABL1 positive: While CXCR4 is present in almost all invasive cancers, CXCR5 has been implicated in advanced stages of chronic myelogenous leukemia, head and neck cancers, colon, and prostate cancer [1,12,29,50].